Home - InteKrin Therapeutics

About > The Company

The Company

InteKrin is a privately held, clinical-stage biopharmaceutical company focused on developing and commercializing INT-131 therapeutics for immune disorders. Diseases such as multiple sclerosis are increasingly in need of novel treatments that provide patients with better treatment alternatives.